Skip to content

Clinical trials

Crohn Disease trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Country / region: Hong Kong Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20114
20122
20131
20161
20174
20186
20193
20201
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Completed8
Unknown status5
Active, not recruiting3
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong13
AbbVie5
Celgene3
GlaxoSmithKline3
Lakefront Biotherapeutics NV2
CSL Behring1
Mak Wing Yan1
Merck Sharp & Dohme LLC1
UCB Pharma SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease30
Colitis, Ulcerative9
Inflammatory Bowel Diseases8
Alcoholism1
Alopecia1
Arthritis, Psoriatic1
Autistic Disorder1
Celiac Disease1
Clostridium Infections1
Constipation1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.